Neurodegenerative Diseases

"Neurodegenerative Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Descriptor ID	D019636
MeSH Number(s)	C10.574
Concept/Terms	Neurodegenerative Diseases Neurodegenerative Diseases Neurodegenerative Disease Degenerative Diseases, Neurologic Neurologic Degenerative Disease Degenerative Neurologic Diseases Degenerative Neurologic Disease Neurologic Disease, Degenerative Neurologic Diseases, Degenerative Nervous System Degenerative Diseases Neurodegenerative Disorders Neurodegenerative Disorder Neurologic Degenerative Conditions Degenerative Condition, Neurologic Degenerative Conditions, Neurologic Neurologic Degenerative Condition Neurologic Degenerative Diseases Degenerative Diseases, Nervous System Degenerative Neurologic Disorders Degenerative Neurologic Disorder Neurologic Disorder, Degenerative Neurologic Disorders, Degenerative Degenerative Diseases, Spinal Cord Degenerative Diseases, Spinal Cord Degenerative Diseases, Central Nervous System Degenerative Diseases, Central Nervous System

Below are MeSH descriptors whose meaning is more general than "Neurodegenerative Diseases".

Diseases [C]
Nervous System Diseases [C10]
Neurodegenerative Diseases [C10.574]

Below are MeSH descriptors whose meaning is related to "Neurodegenerative Diseases".

Below are MeSH descriptors whose meaning is more specific than "Neurodegenerative Diseases".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neurodegenerative Diseases" by people in this website by year, and whether "Neurodegenerative Diseases" was a major or minor topic of these publications.

Bar chart showing 14 publications over 11 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	0	1
2006	0	1	1
2007	1	0	1
2009	0	1	1
2010	1	0	1
2012	1	0	1
2013	1	0	1
2016	2	0	2
2018	0	1	1
2019	3	0	3

Below are the most recent publications written about "Neurodegenerative Diseases" by people in Profiles.

Armstrong A, Mandala A, Malhotra M, Gnana-Prakasam JP. Canonical Wnt Signaling in the Pathology of Iron Overload-Induced Oxidative Stress and Age-Related Diseases. Oxid Med Cell Longev. 2022; 2022:7163326.

View in: PubMed
Burnouf T, Agrahari V, Agrahari V. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation. Int J Nanomedicine. 2019; 14:8847-8859.

View in: PubMed
Thadathil N, Hori R, Xiao J, Khan MM. DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases. Chromosome Res. 2019 12; 27(4):345-364.

View in: PubMed
Royer DJ, Echegaray-Mendez J, Lin L, Gmyrek GB, Mathew R, Saban DR, Perez VL, Carr DJ. Complement and CD4+ T cells drive context-specific corneal sensory neuropathy. Elife. 2019 08 15; 8.

View in: PubMed
Hirose T, Cabrera-Socorro A, Chitayat D, Lemonnier T, Féraud O, Cifuentes-Diaz C, Gervasi N, Mombereau C, Ghosh T, Stoica L, Bacha JDA, Yamada H, Lauterbach MA, Guillon M, Kaneko K, Norris JW, Siriwardena K, Blasér S, Teillon J, Mendoza-Londono R, Russeau M, Hadoux J, Ito S, Corvol P, Matheus MG, Holden KR, Takei K, Emiliani V, Bennaceur-Griscelli A, Schwartz CE, Nguyen G, Groszer M. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. J Clin Invest. 2019 04 15; 129(5):2145-2162.

View in: PubMed
Agrahari V, Burnouf PA, Burnouf T, Agrahari V. Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential. Adv Drug Deliv Rev. 2019 08; 148:146-180.

View in: PubMed
Verla T, Winnegan L, Mayer R, Cherian J, Yaghi N, Palejwala A, Omeis I. Minimally Invasive Transforaminal Versus Direct Lateral Lumbar Interbody Fusion: Effect on Return to Work, Narcotic Use, and Quality of life. World Neurosurg. 2018 Aug; 116:e321-e328.

View in: PubMed
Van Kanegan MJ, Dunn DE, Kaltenbach LS, Shah B, He DN, McCoy DD, Yang P, Peng J, Shen L, Du L, Cichewicz RH, Newman RA, Lo DC. Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke. Sci Rep. 2016 05 12; 6:25626.

View in: PubMed
Mitra RN, Conley SM, Naash MI. Therapeutic Approach of Nanotechnology for Oxidative Stress Induced Ocular Neurodegenerative Diseases. Adv Exp Med Biol. 2016; 854:463-9.

View in: PubMed
Marzetti E, Csiszar A, Dutta D, Balagopal G, Calvani R, Leeuwenburgh C. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am J Physiol Heart Circ Physiol. 2013 Aug 15; 305(4):H459-76.

View in: PubMed

People

Explore

Similar Concepts

Top Journals